Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Hifibio SAS is currently managing a patent portfolio in the Chemistry & Materials technology area. The data shows 1 pending office action. This indicates a singular focus in the current prosecution cycle, as the entire pending workload is concentrated in a single point of review. For a patent practitioner, this means that the immediate results for the portfolio depend on one specific interaction within the USPTO, requiring a focused strategy for this individual matter.
The busiest examiner for this company is THOMPSON, CURTIS A, who is responsible for 1 busiest examiner pending action. Since there is only a single pending office action in total, this individual manages the whole of the company's active office action responses. This concentration in Chemistry & Materials suggests that the company is not currently managing a high volume of simultaneous disputes or reviews across different examiners, which may allow for more dedicated attention to this specific case.
Navigating prosecution with a single distinct art unit requires a highly tailored approach to the standards of that specific group. The lack of diversity in examiners for the pending workload means there are no internal benchmarks for comparison within the portfolio. Practitioners must rely on the specific feedback from THOMPSON, CURTIS A to guide the strategy for the pending applications, ensuring that the response aligns with the examiner's particular preferences and the art unit's established guidelines.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMPSON, CURTIS A | 1 | 60.8% | +52.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17260000 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | THOMPSON, CURTIS A | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17260000 | USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION | THOMPSON, CURTIS A | 1798 | §103Other | Non-Final OA | 5d overdue | Pending | Jan 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial